Barry Canton - 26 Oct 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Oct 2022, 18:49:57 UTC
Prior SEC filing
26 Oct 2022
Next SEC filing
01 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Karen Tepichin, Attorney-in-Fact

Key filing fact

Barry Canton filed Form 4 for Ginkgo Bioworks Holdings, Inc. (DNA) on 28 Oct 2022.

Key facts

  • This page summarizes Barry Canton's Form 4 filing for Ginkgo Bioworks Holdings, Inc. (DNA).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Oct 2022, 18:49.

Change

  • Previous filing in this sequence was filed on 26 Oct 2022.
  • Current net transaction value: -$2,205,146.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DNA transaction

Class A Common Stock

Sale

Transaction value
$549,257
Shares
-189,138
Change %
-0.8%
Price
$2.90
Shares after
23,578,070
Date
26 Oct 2022
Ownership
Direct
Footnotes
F1
DNA transaction

Class A Common Stock

Sale

Transaction value
$549,257
Shares
-189,138
Change %
-0.8%
Price
$2.90
Shares after
23,578,068
Date
26 Oct 2022
Ownership
By Spouse
Footnotes
F1
DNA transaction

Class A Common Stock

Sale

Transaction value
$553,317
Shares
-204,478
Change %
-0.87%
Price
$2.71
Shares after
23,373,592
Date
27 Oct 2022
Ownership
Direct
Footnotes
F1
DNA transaction

Class A Common Stock

Sale

Transaction value
$553,315
Shares
-204,477
Change %
-0.87%
Price
$2.71
Shares after
23,373,591
Date
27 Oct 2022
Ownership
By Spouse
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .